acalabrutinib, cyclophosphamide. One increases the toxicity of the other through pharmacodynamic synergism. Use caution/monitoring. Co-administration may increase the risk of myelosuppressive effects.
Allopurinol increases the toxicity of cyclophosphamide by decreasing its metabolism. Use caution/monitoring.
Amiodarone increases the toxicity of cyclophosphamide through an unspecified mechanism of interaction. Use caution/monitoring.
Cyclophosphamide potentiates the effects of antithrombin III by an unknown mechanism. Use caution/monitoring.
Cyclophosphamide potentiates the effects of argatroban through an unknown mechanism. Use caution/monitoring. In patients with thrombocytopenia receiving antineoplastic agents in combination with argatroban, there may be an additional risk of bleeding because these agents may reduce the number of platelets in the blood.
Atazanavir increases the level or effect of cyclophosphamide by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Use caution/monitoring.Atazanavir increases the toxicity of cyclophosphamide through an unspecified mechanism of interaction. Use caution/monitoring.
Belatacept and cyclophosphamide potentiate the immunosuppressive effect; risk of infection. Use caution/monitoring.
Belzutifan decreases the level or effect of cyclophosphamide by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Modify/closely monitor therapy. If co-administration of belzutifan with sensitive CYP3A4 substrates cannot be avoided, consider increasing the dose of the sensitive CYP3A4 substrate in accordance with the prescribing information.
bendamustine, cyclophosphamide. One increases the toxicity of the other through pharmacodynamic synergism. Use caution/monitoring. Additive myelosuppression.
Cyclophosphamide potentiates the effects of bivalirudin by an unknown mechanism. Use caution/monitoring. There may be an additional risk of bleeding in patients with thrombocytopenia receiving antineoplastic agents in combination with anticoagulants such as bivalirudin.
Cyclophosphamide implant, bupivacaine. One increases the toxicity of the other for the others (see comment). Use caution/monitoring. Comment: Local anesthetics may increase the risk of methemoglobinemia when concomitantly exposed to drugs that also cause methemoglobinemia.
cyclophosphamide, busulfan. One increases the toxicity of the other through pharmacodynamic synergism. Use caution/monitoring.busulfan, cyclophosphamide. One increases the toxicity of the other through pharmacodynamic synergism. Use caution/monitoring. Additive myelosuppression.
Butabarbital decreases the level or effect of cyclophosphamide by affecting the metabolism of the liver enzyme CYP2B6. Use caution/monitoring.
cannabidiol, cyclophosphamide. Effects on the metabolism of the hepatic enzyme CYP2B6. Modify/closely monitor therapy. Due to the potential for CYP2B6 induction and inhibition with co-administration of CYP2B6 substrates and cannabidiol, a reduced dose titration of CYP2B6 substrates should be considered when clinically appropriate.
Carbamazepine decreases the level or effect of cyclophosphamide by affecting the metabolism of the liver enzyme CYP2B6. Use caution/monitoring.
carboplatin, cyclophosphamide. One increases the toxicity of the other through pharmacodynamic synergism. Use caution/monitoring. Additive myelosuppression.
carmustine, cyclophosphamide. One increases the toxicity of the other through pharmacodynamic synergism. Use caution/monitoring. Additive myelosuppression.
Cenobamate decreases the level or effect of cyclophosphamide by affecting the metabolism of the liver enzyme CYP2B6. Modify/closely monitor therapy. If necessary, increase the CYP2B6 substrate dose when co-administered with cenobamate.Cenobamate decreases the level or effect of cyclophosphamide by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Modify/closely monitor therapy. If necessary, increase the CYP3A4 substrate dose when co-administered with cenobamate.
chlorambucil, cyclophosphamide. One increases the toxicity of the other through pharmacodynamic synergism. Use caution/monitoring. Additive myelosuppression.
Cyclophosphamide reduces the efficacy of the cholera vaccine through immunosuppressive effects; risk of infection. Modify/closely monitor therapy. Immunosuppressive therapies including radiation, antimetabolites, alkylating agents, cytostatics, and corticosteroids (used in higher than physiological doses) may reduce the immune response to cholera vaccine.
cisplatin, cyclophosphamide. One increases the toxicity of the other through pharmacodynamic synergism. Use caution/monitoring. Additive myelosuppression.
Cyclophosphamide increases the level or effect of crizotinib by inhibiting aldehyde dehydrogenase. Use caution/monitoring.
Crofelemer increases cyclophosphamide levels by affecting the metabolism of the intestinal/hepatic enzyme CYP3A4. Use caution/monitoring. Crofelemer has the potential to inhibit CYP3A4 at expected concentrations in the intestine; Systemic inhibition is unlikely as it is only minimally absorbed.
Dabrafenib decreases the level or effect of cyclophosphamide by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Modify/closely monitor therapy.
cyclophosphamide, dacarbazine. One increases the toxicity of the other through pharmacodynamic synergism. Use caution/monitoring. Additive myelosuppression.
Cyclophosphamide potentiates the effects of dalteparin by an unknown mechanism. Use caution/monitoring. Due to the possible thrombocytopenic effects of cyclophosphamide, an additional risk of bleeding may be observed in patients receiving concomitant anticoagulants.
Darunavir increases the level or effect of cyclophosphamide by affecting the metabolism of the intestinal/hepatic enzyme CYP3A4. Use caution/monitoring.
Cyclophosphamide decreases the effect of the dengue vaccine through immunosuppressive effects; risk of infection. Use caution/monitoring. Immunosuppressive therapies (eg, radiation, antimetabolites, alkylating agents, cytotoxic drugs, corticosteroids [higher than physiologic doses]) may reduce the immune response to dengue vaccine.
cyclophosphamide, denosumab. Others (see comment). Use caution/monitoring. Comment: Caution is advised in patients taking concomitant immunosuppressants or with a compromised immune system, as there is an increased risk of serious infections.
Cyclophosphamide reduces digoxin levels by inhibiting gastrointestinal absorption. Applies only to the oral form of both active ingredients. Use caution/monitoring.
Doxorubicin increases the toxicity of cyclophosphamide through an unspecified mechanism of interaction. Use caution/monitoring. Increased risk of hemorrhagic cystitis.
Liposomal doxorubicin increases the toxicity of cyclophosphamide through an unspecified mechanism of interaction. Use caution/monitoring. Increased risk of hemorrhagic cystitis.
Efavirenz decreases the level or effect of cyclophosphamide by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Use caution/monitoring.
elagolix decreases the level or effect of cyclophosphamide by affecting the metabolism of the intestinal/hepatic enzyme CYP3A4. Modify/closely monitor therapy. Elagolix is a weak to moderate CYP3A4 inducer. Monitor CYP3A substrates when co-administered. Consider increasing the CYP3A substrate dose if necessary.
Elvitegravir/cobicistat/emtricitabine/tenofovir DF increases cyclophosphamide levels by interfering with hepatic/intestinal metabolism of the CYP3A4 enzyme. Modify/closely monitor therapy. Cobicistat is a CYP3A4 inhibitor; Contraindicated with CYP3A4 substrates where elevated plasma concentrations are associated with serious and/or life-threatening events.
Cyclophosphamide potentiates the effects of enoxaparin by an unknown mechanism. Use caution/monitoring. Due to the possible thrombocytopenic effects of cyclophosphamide, an additional risk of bleeding may be observed in patients receiving concomitant anticoagulants.
Fedratinib increases the level or effect of cyclophosphamide by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Use caution/monitoring. Adjust the dose of drugs that are CYP3A4 substrates as needed.
Cyclophosphamide potentiates the effects of fingolimod through immunosuppressive effects; risk of infection. Modify/closely monitor therapy. Concomitant therapy is expected to increase the risk of immunosuppression. Be careful when switching patients from long-term therapies with immunological effects. .
Fluvoxamine increases the level or effect of cyclophosphamide by affecting the metabolism of the liver enzyme CYP2B6. Use caution/monitoring.
Cyclophosphamide potentiates the effects of fondaparinux by an unknown mechanism. Use caution/monitoring. Due to the possible thrombocytopenic effects of cyclophosphamide, an additional risk of bleeding may be observed in patients receiving concomitant anticoagulants.
Cyclophosphamide potentiates the effects of heparin by an unknown mechanism. Use caution/monitoring. Due to the possible thrombocytopenic effects of cyclophosphamide, an additional risk of bleeding may be observed in patients receiving concomitant anticoagulants.
Cyclophosphamide, Hydroxyurea. Others (see comment). Use caution/monitoring. Comment: The combination may increase the risk of myelosuppression.
cyclophosphamide, ifosfamide. One increases the toxicity of the other through pharmacodynamic synergism. Use caution/monitoring. Additive myelosuppression.Ifosfamide, Cyclophosphamide. One increases the toxicity of the other through pharmacodynamic synergism. Use caution/monitoring. Concomitant use with ifosfamide may increase the risk of immunosuppression and myelosuppression.
Iloperidone increases cyclophosphamide levels by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Use caution/monitoring. Iloperidone is a time-dependent inhibitor of CYP3A and may cause increased plasma levels of drugs that are primarily cleared by CYP3A4.
Indinavir increases the level or effect of cyclophosphamide by affecting the metabolism of the intestinal/hepatic enzyme CYP3A4. Use caution/monitoring.
Cyclophosphamide reduces the effect of the influenza A (H5N1) vaccine through pharmacodynamic antagonism. Use caution/monitoring. Immunosuppressive therapies can reduce the immune response to the H5N1 vaccine.
Cyclophosphamide reduces the effect of the influenza (H5N1) vaccine with the help of pharmacodynamic antagonism. Use caution/monitoring. Immunosuppressive therapies can reduce the immune response to the H5N1 vaccine.
Cyclophosphamide and isavuconazone sulfate reduce immunosuppressive effects; risk of infection. Use caution/monitoring.
Istradefylline increases the level or effect of cyclophosphamide by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Use caution/monitoring. Istradefylline 40 mg/day increased the peak levels and AUC of CYP3A4 substrates in clinical studies. This effect was not seen with istradefylline 20 mg/day. Consider reducing the dose of sensitive CYP3A4 substrates.
Ketoconazole increases the toxicity of cyclophosphamide by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Use caution/monitoring.
Lemborexant decreases the level or effect of cyclophosphamide by affecting the metabolism of the liver enzyme CYP2B6. Modify/closely monitor therapy. Monitor CYP2B6 substrate for adequate clinical response. Consider increasing the CYP2B6 substrate dose according to specific prescribing recommendations.
Lenacapavir increases the level or effect of cyclophosphamide by affecting the metabolism of the intestinal/hepatic enzyme CYP3A4. Use caution/monitoring. Lencapavir (a moderate CYP3A4 inhibitor) may increase CYP3A4 substrates initiated 9 months after the last subcutaneous administration of lenacapavir, which may increase the potential risk of adverse reactions to CYP3A4 substrates.
Letermovir increases cyclophosphamide levels by affecting hepatic/intestinal metabolism of the CYP3A4 enzyme. Use caution/monitoring.
cyclophosphamide, lomustine. One increases the toxicity of the other through pharmacodynamic synergism. Use caution/monitoring. Additive myelosuppression.lomustine, cyclophosphamide. One increases the toxicity of the other through pharmacodynamic synergism. Use caution/monitoring. Concomitant use with lomustine may increase the risk of immunosuppression and myelosuppression.
Lopinavir increases the level or effect of cyclophosphamide by affecting the metabolism of the intestinal/hepatic enzyme CYP3A4. Use caution/monitoring.
Lumacaftor/ivacaftor, cyclophosphamide. Effects on the metabolism of the hepatic enzyme CYP2B6. Use caution/monitoring. In vitro studies indicate that lumacaftor can induce CYP2B6 substrates and inhibit ivacaftor. .
cyclophosphamide, mechlorethamine. One increases the toxicity of the other through pharmacodynamic synergism. Use caution/monitoring. Concomitant use with mechlorethamine may increase the risk of immunosuppression and myelosuppression.mechlorethamine, cyclophosphamide. One increases the toxicity of the other through pharmacodynamic synergism. Use caution/monitoring. Concomitant use with mechlorethamine may increase the risk of immunosuppression and myelosuppression.
Cyclophosphamide reduces the effect of the group B meningococcal vaccine by pharmacodynamic antagonism. Use caution/monitoring. People with impaired immunocompetence may have a reduced immune response to the vaccine.
Mifepristone increases the level or effect of cyclophosphamide by affecting the metabolism of the liver enzyme CYP2B6. Use caution/monitoring.Mifepristone increases the level or effect of cyclophosphamide by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Use caution/monitoring.
Mitotane reduces cyclophosphamide levels by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Use caution/monitoring. Mitotane is a potent inducer of cytochrome P-4503A4; Monitor possible dose adjustments when co-administered with CYP3A4 substrates.
Nelfinavir increases the level or effect of cyclophosphamide by affecting the metabolism of the intestinal/hepatic enzyme CYP3A4. Use caution/monitoring.
Cyclophosphamide and ocrelizumab increase the immunosuppressive effect; risk of infection. Use caution/monitoring. Concomitant use of ocrelizumab with immunosuppressants may increase the risk of immunosuppression.
Ofatumumab SC, cyclophosphamide. One potentiates the action of the other through immunosuppressive effects; risk of infection. Use caution/monitoring. Consider the risk of additive effects on the immune system when using concomitant immunosuppressive therapies. When switching from therapies with immunological effects, consider the duration and mechanism of action of these therapies when initiating ofatumumab SC.
Cyclophosphamide and olaparib improve pharmacodynamic synergy. Use caution/monitoring. Co-administration with other myelosuppressive anticancer agents, including DNA-damaging agents, may increase and prolong myelosuppressive toxicity.
Pentobarbital decreases the level or effect of cyclophosphamide by affecting the metabolism of the liver enzyme CYP2B6. Use caution/monitoring.
Phenobarbital decreases the level or effect of cyclophosphamide by affecting the metabolism of the liver enzyme CYP2B6. Use caution/monitoring.
Primidone decreases the level or effect of cyclophosphamide by affecting the metabolism of the liver enzyme CYP2B6. Use caution/monitoring.
Rifampin decreases the level or effect of cyclophosphamide by affecting the metabolism of the liver enzyme CYP2B6. Use caution/monitoring.Rifampicin decreases the level or effect of cyclophosphamide by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Use caution/monitoring.
Ritonavir increases the level or effect of cyclophosphamide by affecting the metabolism of the liver enzyme CYP2B6. Use caution/monitoring.Ritonavir increases the level or effect of cyclophosphamide by affecting the metabolism of the intestinal/hepatic enzyme CYP3A4. Use caution/monitoring.
Rucaparib increases the level or effect of cyclophosphamide by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Modify/closely monitor therapy. Adjust the dose of CYP3A4 substrates as clinically indicated.
Saquinavir increases the level or effect of cyclophosphamide by affecting the metabolism of the intestinal/hepatic enzyme CYP3A4. Use caution/monitoring.
Secobarbital decreases the level or effect of cyclophosphamide by affecting the metabolism of the hepatic enzyme CYP2B6. Use caution/monitoring.
Siponimod and cyclophosphamide potentiate the immunosuppressive effect; risk of infection. Use caution/monitoring. Caution with co-administration due to additional immunosuppressive effects during co-administration and in the weeks following dosing. When changing medications with prolonged immunological effects, consider the half-life and mode of action of these medications to avoid unwanted additive immunosuppressive effects.
Cyclophosphamide reduces the effect of sipuleucel-T by pharmacodynamic antagonism. Modify/closely monitor therapy.
Sodium sulfate/magnesium sulfate/potassium chloride increases the toxicity of cyclophosphamide to others (see comment). Use caution/monitoring. Comment: Co-administration with drugs that cause electrolyte abnormalities may increase the risk of side effects such as seizures, arrhythmias, and renal dysfunction.
Sodium sulfate/potassium sulfate/magnesium sulfate increases the toxicity of cyclophosphamide to others (see comment). Use caution/monitoring. Comment: Co-administration with drugs that cause electrolyte abnormalities may increase the risk of side effects such as seizures, arrhythmias, and renal dysfunction.
Sorafenib increases the level or effect of cyclophosphamide by affecting the metabolism of the hepatic enzyme CYP2B6. Use caution/monitoring.
Sparsentan decreases the level or effect of cyclophosphamide by affecting the metabolism of the liver enzyme CYP2B6. Use caution/monitoring. Sparsentan (a CYP2B6 inducer) decreases exposure to CYP2B6 substrates and decreases the efficacy associated with these substrates.
stiripentol, cyclophosphamide. Effects on the metabolism of the hepatic enzyme CYP2B6. Modify/closely monitor therapy. Stiripentol is an inhibitor and inducer of CYP2B6. Monitor CYP2B6 substrates co-administered with stiripentol for increased or decreased effects. Dose adjustment may be required for CYP2B6 substrates.stiripentol, cyclophosphamide. Effects on CYP3A4 hepatic/intestinal enzyme metabolism. Modify/closely monitor therapy. Stiripentol is an inhibitor and inducer of CYP3A4. Monitor CYP3A4 substrates co-administered with stiripentol for increased or decreased effects. CYP3A4 substrates may require dose adjustment.
Cyclophosphamide, streptozocin. One increases the toxicity of the other through pharmacodynamic synergism. Use caution/monitoring. Additive myelosuppression.
Cyclophosphamide increases succinylcholine levels by slowing metabolism. Use caution/monitoring. Neuromuscular blockade may be prolonged due to inhibition of cholinesterase activity. Persistent respiratory depression can occur with longer periods of apnea. .
Tecovirimat decreases the level or effect of cyclophosphamide by affecting the metabolism of the intestinal/hepatic enzyme CYP3A4. Use caution/monitoring. Tecovirimat is a weak inducer of CYP3A4. Monitor the efficacy of sensitive CYP3A4 substrates when co-administered.
Cyclophosphamide, Thiotepa. One increases the toxicity of the other through pharmacodynamic synergism. Use caution/monitoring. Additive myelosuppression.
Tipranavir increases the level or effect of cyclophosphamide by affecting the metabolism of the intestinal/hepatic enzyme CYP3A4. Use caution/monitoring.
trastuzumab, cyclophosphamide. One increases the toxicity of the other through immunosuppressive effects; risk of infection. Use caution/monitoring. Neutropenia or febrile neutropenia was more common when trastuzumab was given together with myelosuppressive chemotherapy. .
Trastuzumab deruxtecan, cyclophosphamide. One increases the toxicity of the other through immunosuppressive effects; risk of infection. Use caution/monitoring. Neutropenia or febrile neutropenia was more common when trastuzumab was given together with myelosuppressive chemotherapy. .
Ublituximab and cyclophosphamide potentiate the immunosuppressive effect; risk of infection. Modify/closely monitor therapy. Due to possible additive immunosuppressive effects, the duration and mechanism of action of these therapies should be taken into account when used concurrently.
voclosporin, cyclophosphamide. One increases the toxicity of the other through nephrotoxicity and/or ototoxicity. Modify/closely monitor therapy. Co-administration with medicinal products associated with nephrotoxicity may increase the risk of acute and/or chronic nephrotoxicity.
Cyclophosphamide increases the level or effect of abemaciclib by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of abiraterone by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of acalabrutinib by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Acetazolamide increases the level or effect of cyclophosphamide by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of ado-trastuzumab emtansine by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of alfentanil by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of alfuzosin by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of alpelisib by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of alprazolam by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of ambrisentan by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of amiodarone by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of amlodipine by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Anastrozole increases the level or effect of cyclophosphamide by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of apalutamide by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of apixaban by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of apomorphine by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide decreases the level or effect of apremilast by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of aprepitant by affecting the metabolism of the intestinal/hepatic enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of aripiprazole by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of armodafinil by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide decreases the level or effect of artemether/lumefantrine by affecting the metabolism of the intestinal/hepatic enzyme CYP3A4. Minor/Unknown meaning.
Aspirin decreases the level or effect of cyclophosphamide by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of astemizole by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of atazanavir by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of atogepant by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of atorvastatin by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of avanafil by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of avapritinib by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of avatrombopag by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases axitinib levels by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of bedaquiline by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of benzhydrocodone/acetaminophen by affecting the metabolism of the intestinal/hepatic enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of benzphetamine by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of bortezomib by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of bosentan by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of bosutinib by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of brentuximab vedotin by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of brexpiprazole by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of brigatinib by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of bromocriptine by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of budesonide by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of buprenorphine by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of transdermal buprenorphine by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of buspirone by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of busulfan by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of cabozantinib by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of calcifediol by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide will increase the level or effect of calcitriol by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of capmatinib by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of carbamazepine by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of cariprazine by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of chlordiazepoxide by affecting the metabolism of the intestinal/hepatic enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of chloroquine by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of chlorpheniramine by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of inhaled ciclesonide by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of cilostazol by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of cisapride by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of citalopram by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of clarithromycin by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of clonazepam by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of clorazepate by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of cobicistat by affecting the metabolism of the intestinal/hepatic enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of cobimetinib by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of topical cocaine by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of colchicine by affecting the metabolism of the intestinal/hepatic enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of conivaptan by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of conjugated estrogens by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of copanlisib by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of cyclosporine by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of dabrafenib by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of daclatasvir by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of dantrolene by affecting the metabolism of the intestinal/hepatic enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of dapsone by affecting the metabolism of the intestinal/hepatic enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of darifenacin by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of darunavir by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of dasatinib by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of deflazacort by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of delavirdine by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of dexamethasone by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of dexlansoprazole by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of diazepam by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of intranasal diazepam by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of dihydroergotamine by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of intranasal dihydroergotamine by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of diltiazem by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of disopyramide by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of docetaxel by affecting the metabolism of the intestinal/hepatic enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of doravirine by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of doxepin cream by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of doxorubicin by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of liposomal doxorubicin by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of dronabinol by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of dronedarone by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of duvelisib by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of efavirenz by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of elagolix by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of elbasvir/grazoprevir by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of eletriptan by affecting the metabolism of the intestinal/hepatic enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of eliglustat by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of elvitegravir by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of elvitegravir/cobicistat/emtricitabine/tenofovir DF by affecting the metabolism of the intestinal/hepatic enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of encorafenib by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of enfortumab vedotin by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of entrectinib by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of enzalutamide by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of eplerenone by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of ergoloid mesylates by affecting metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of ergonovine by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of ergotamine by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of erlotinib by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of erythromycin base by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of erythromycin ethylsuccinate by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of erythromycin lactobionate by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of erythromycin stearate by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of escitalopram by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of esomeprazole by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of estradiol by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of synthetic conjugated estrogens by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of esterified estrogens by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of estropipate by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of eszopiclone by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of ethinylestradiol by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of ethosuximide by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of etoposide by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of etravirine by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of everolimus by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of exemestane by affecting the metabolism of the intestinal/hepatic enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of fedratinib by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of felbamate by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of felodipine by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of fenofibrate by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of micronized fenofibrate by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of fenofibric acid by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of fentanyl by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of intranasal fentanyl by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of transdermal fentanyl by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the transmucosal level or effect of fentanyl by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of finerenone by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of flibanserin by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of inhaled flunisolide by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of flurazepam by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of flutamide by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of fluticasone furoate by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of inhaled fluticasone by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of fosamprenavir by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of fosaprepitant by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of fostamatinib by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of gefitinib by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of glasdegib by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of glecaprevir/pibrentasvir by affecting the metabolism of the intestinal/hepatic enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of guanfacine by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of haloperidol by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of hydrocodone by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of hydroxyprogesterone caproate by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of ibrutinib by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of idelalisib by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of ifosfamide by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of imatinib by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of indinavir by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of irinotecan by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of liposomal irinotecan by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of isavuconazone sulfate by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of isosorbide dinitrate by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of isosorbide mononitrate by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of isradipine by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of istradefylline by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of itraconazole by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of ivacaftor by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of ivosidenib by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of ixabepilone by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of ixazomib by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of ketamine by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of lacosamide by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of lansoprazole by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of lapatinib by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Larotrectinib increases the level or effect of cyclophosphamide by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.Cyclophosphamide increases the level or effect of larotrectinib by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of lemborexant by affecting the metabolism of the intestinal/hepatic enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of levamlodipine by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Levoketoconazole increases the level or effect of cyclophosphamide by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of levomilnacipran by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the intrauterine level or effect of levonorgestrel by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of oral levonorgestrel by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of linagliptin by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases lomitapide levels by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of lonafarnib by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of lopinavir by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of lorlatinib by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of losartan by affecting the metabolism of the intestinal/hepatic enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of lovastatin by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of lumacaftor/ivacaftor by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of lumefantrine by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of lurasidone by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of macimorelin by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of maraviroc by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the levels or effects of marijuana by affecting the metabolism of the liver/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of medroxyprogesterone by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of mefloquine by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of mestranol by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide will increase the level or effect of metaxalone by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of methadone by affecting the metabolism of the intestinal/hepatic enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of methylergonovine by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of methylprednisolone by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of oral miconazole by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of midazolam by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide will increase the level or effect of intranasal midazolam by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of midostaurin by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of mifepristone by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of mirtazapine by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of modafinil by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide will increase the level or effect of montelukast by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of naldimedine by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of naloxegol by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of nefazodone by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of nelfinavir by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of netupitant/palonosetron by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of nevirapine by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of nicardipine by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of nifedipine by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of nilotinib by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of nimodipine by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of nisoldipine by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of norethindrone by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of norgestrel by affecting the metabolism of the intestinal/hepatic enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of olaparib by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of ombitasvir/paritaprevir/ritonavir by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of ombitasvir/paritaprevir/ritonavir and dasabuvir (DSC) by affecting hepatic/intestinal metabolism of the CYP3A4 enzyme. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of omeprazole by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of ondansetron by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of osilodrostat by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of osimertinib by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of ospemifene by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of oxycodone by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of paclitaxel by affecting the metabolism of the intestinal/hepatic enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide will increase the level or effect of paclitaxel binding protein by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide will increase the level or effect of palbociclib by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of panobinostat by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of paricalcitol by affecting the metabolism of the intestinal/hepatic enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of pazopanib by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of perampanel by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of pexidartinib by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of pimavanserin by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of pimozide by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of pitolisant by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of polatuzumab vedotin by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of pomalidomide by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of ponatinib by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of praziquantel by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of primaquine by affecting the metabolism of the intestinal/hepatic enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of intravaginal progesterone gel by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of micronized progesterone by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of progesterone naturally by affecting the hepatic/intestinal metabolism of the CYP3A4 enzyme. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of quazepam by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of quetiapine by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of quinidine by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of quinine by affecting the metabolism of the intestinal/hepatic enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of rabeprazole by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of ranolazine by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of regorafenib by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of repaglinide by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Ribociclib increases the level or effect of cyclophosphamide by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.Cyclophosphamide increases the level or effect of ribociclib by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of rifabutin by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of rimegepant by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of riociguat by affecting the metabolism of the intestinal/hepatic enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of ritonavir by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of rivaroxaban by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of roflumilast by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of ropitant by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of romidepsin by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of ropivacaine by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of ruxolitinib by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of topical ruxolitinib by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of salmeterol by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of saquinavir by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of saxagliptin by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of selpercatinib by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of sildenafil by affecting the metabolism of the intestinal/hepatic enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of simvastatin by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of siponimod by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of sirolimus by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the concentration or effect of sofosbuvir/velpatasvir by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of solifenacin by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of sonidegib by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of sorafenib by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of stiripentol by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide will increase the level or effect of sufentanil by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of sufentanil SL by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of sunitinib by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of suvorexant by affecting the metabolism of the intestinal/hepatic enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of tacrolimus by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of tacrolimus ointment by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of tadalafil by affecting the metabolism of the intestinal/hepatic enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide reduces the effect of tamoxifen by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of tamsulosin by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the concentration or effect of tasimelteon by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of tazemetostat by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of temsirolimus by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of teniposide by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of tetracycline by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of tezacaftor by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of theophylline by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of tiagabine by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of ticagrelor by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of ticlopidine by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of tinidazole by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of tipranavir by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of tofacitinib by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of tolterodine by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of tolvaptan by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of toremifene by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of trabectedin by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of tramadol by affecting the metabolism of the intestinal/hepatic enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of trazodone by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of triazolam by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of trimethoprim by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of trimipramine by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of ubrogepant by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of ulipristal by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of inhaled umeclidinium bromide/vilanterol by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of upadacitinib by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of valbenazine by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of vandetanib by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of vardenafil by affecting the metabolism of the intestinal/hepatic enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of velpatasvir by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of vemurafenib by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of venetoclax by affecting the metabolism of the intestinal/hepatic enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of venlafaxine by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of verapamil by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of inhaled vilanterol furoate/fluticasone by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of vilazodone by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of vinblastine by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of vincristine by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of liposomal vincristine by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of vinorelbine by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of vorapaxar by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of voriconazole by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of vortioxetine by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of voxilaprevir by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Warfarin decreases the level or effect of cyclophosphamide by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of zanubrutinib by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of zolpidem by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.
Cyclophosphamide increases the level or effect of zonisamide by affecting the metabolism of the hepatic/intestinal enzyme CYP3A4. Minor/Unknown meaning.